The molecular spectroscopy market is expected to reach USD 6.85 Billion by 2022 from an estimated USD 4.98 Billion in 2017, at a CAGR of 6.6%.
Seattle, WA -- (SBWIRE) -- 10/17/2017 -- The report "Molecular Spectroscopy Market by Technology (NMR (FT, Continuous Wave), UV-Visible (Array-based, Dual-beam), IR (Terahertz, Benchtop), NIR (FT-NIR), Raman (SERS, TERS, FT Raman)), Application (Pharmaceutical, Food, Biotechnology) - Global Forecast to 2022", The molecular spectroscopy market is expected to reach USD 6.85 Billion by 2022 from an estimated USD 4.98 Billion in 2017, at a CAGR of 6.6%. The key factors driving the growth of this market include the growth of the pharmaceutical and biotechnology industry and technological advancements in molecular spectroscopy are driving the growth of the global molecular spectroscopy market during the forecast period. The growing use of molecular spectroscopy in emerging markets and the rising potential for the application of terahertz spectroscopy in healthcare are the key areas of opportunity in this market.
Browse 161 Market Data Tables and 34 Figures spread through 217 Pages and in-depth TOC on "Molecular Spectroscopy Market"
Early buyers will receive 10% customization on reports.
By technology, the NMR spectroscopy segment accounted for the largest share of the market in 2017
On the basis of technology, the molecular spectroscopy market is broadly segmented into nuclear magnetic resonance (NMR) spectroscopy, UV-Visible spectroscopy, infrared (IR) spectroscopy, near-infrared spectroscopy, color measurement spectroscopy, raman spectroscopy, and other technologies (fluorescence spectroscopy and hybrid spectroscopy). In 2017, the NMR spectroscopy segment is expected to account for the largest share of this market. The extensive applications of NMR spectroscopy coupled with the technological advancements in molecular spectroscopy are driving the growth of this segment.
By application, the pharmaceutical application industry held the largest market share in 2017
Based on application, the molecular spectroscopy market is further segmented into pharmaceutical application, biotechnology and biopharmaceutical applications, environmental testing, food and beverage testing, academic research, and other applications. In 2017, the pharmaceutical applications segment is expected to account for the largest share. Extensive use of molecular spectroscopy technologies at various stages of drug development processes and increase in R&D investments by pharmaceutical industries is driving the growth of the market.
Download PDF Brochure: - http://www.marketsandmarkets.com/pdfdownload.asp?id=50034395
North America dominated the market in 2017
North America accounted for the largest share of the molecular spectroscopy market in 2016, followed by Europe. High usage of molecular spectroscopy in the pharmaceutical sector, growing funding for environmental testing in the US, growing food safety concerns in the US, and government initiatives to improve lab infrastructure and propel fundamental scientific research in Canada will drive market growth during the forecast period.
Factors such as rising importance of food safety, growing biotechnology and pharmaceutical industry in UK, Germany and Italy, funding in the life science sector, Russia's booming pharmaceutical industry and rising research investment in European countries; are significant growth opportunities for the players competing in the global molecular spectroscopy market during the forecast period.
Bruker Corporation (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), and Agilent Technologies, Inc. (US) are the key players in the molecular spectroscopy market. Other players include Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US).
Atomic Spectroscopy Market by Technology (Atomic Absorption Spectroscopy/X-Ray Fluorescence/X-Ray Diffraction/ICP-MS/ICP-OES) & by Application (Food & Beverage Testing/Pharmaceuticals & Biotechnology / Environmental Testing) - Analysis & Global Forecast to 2020
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States